Close Menu

NEW YORK (GenomeWeb) – Ginkgo Bioworks today announced it has acquired several assets from Warp Drive Bio, a subsidiary of Revolution Medicines, including its genome mining platform.

Warp Drive's bioinformatics technology sifts through microbial genome databases to uncover potential antibiotics. Its genomic database includes more than 135,000 bacterial strains.

Under the terms of the deal, Ginkgo will obtain Warp Drive's genomic sequence collection and bioinformatics software. Warp Drive's genome mining team will also move to Ginkgo's headquarters in Boston.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The nonprofit Biden Cancer Initiative is suspending its operations, according to the Associated Press.

Researchers examine how white nationalists handle personal genetic ancestry results that conflict with their racist worldview, the New York Times reports.

NPR speaks with research participants before and after they learn their APOE E4 status, which affects their risk of developing Alzheimer's disease.

In PLOS this week: genetic characterization of Toxoplasma gondii strains, Crimean-Congo Hemorrhagic Fever Virus uncovered in Sudan, and more.

Sponsored by
BC Platforms

This webinar will discuss how the Estonian Biobank, a cohort of more than 165,000 participants, is addressing industry challenges with data management and collaboration in the transition to precision medicine.